Skip to main content

Together we are beating cancer

Donate now

Cancer News

Latest News

Showing 12 out of 6195 results
spatial transcriptomics

Our Research is Beautiful campaign continues to inspire with some fantastic images, but there has to be a winner, and here’s January’s… Our Research is Beautiful campaign continues to inspire with some fantastic images, but there has to be a winner, and here’s January’s…

by Phil Prime | In depth | 3 February 2025

3 February 2025

This entry is part 11 of 19 in the series Research is Beautiful
%postcontent%
Lab-grown bowel cancer cells seen through a microscope. They are colour-enhanced and appear blue.

A new testing technique with genome sequencing is 90% accurate at predicting which high-risk people with IBD will develop bowel cancer, according to a study by our scientists.  A new testing technique with genome sequencing is 90% accurate at predicting which high-risk people with IBD will develop bowel cancer, according to a study by our scientists. 

by Tim Gunn | News | 30 January 2025

30 January 2025

loyalty cards

The idea of using shopping behaviour as an early signal of ovarian cancer is certainly thinking outside the box, but could it work? The idea of using shopping behaviour as an early signal of ovarian cancer is certainly thinking outside the box, but could it work?

by Cancer Research UK | In depth | 28 January 2025

28 January 2025

A group of three Cancer Research UK scientists Group of researchers looking at a data file in a lab

A first-of-its-kind drug that protects the hearing of babies, children and young people undergoing cancer treatment has been approved for NHS use in England, based on the results of one of our trials.   A first-of-its-kind drug that protects the hearing of babies, children and young people undergoing cancer treatment has been approved for NHS use in England, based on the results of one of our trials.  

by Tim Gunn | News | 28 January 2025

28 January 2025

A microscope image showing immune cells in bowel cancer.

A new AI test that looks at immune cells could help people with stage 2 bowel cancer avoid chemotherapy after surgery, cutting side effects. A new AI test that looks at immune cells could help people with stage 2 bowel cancer avoid chemotherapy after surgery, cutting side effects.

by Sadaf Shafaghmotlagh, Tim Gunn | Analysis | 27 January 2025

27 January 2025

Salmonella bacteria (rod-shaped organisms coloured blue) in a bowel cancer tumour (coloured beige). The bacteria looks like it is rushing into a hole in the tumour tissue.

Our researchers are modifying Salmonella bacteria into a treatment that can work with the immune system to attack bowel cancer from two sides at once. Our researchers are modifying Salmonella bacteria into a treatment that can work with the immune system to attack bowel cancer from two sides at once.

by Tim Gunn, Fiona MacLeod | News | 23 January 2025

23 January 2025

Health data

Understanding cancer risk is key to early detection, and the Cancer Data Driven Detection – or CD3 – project aims to do so in an unprecedented fashion Understanding cancer risk is key to early detection, and the Cancer Data Driven Detection – or CD3 – project aims to do so in an unprecedented fashion

by Cancer Research UK | In depth | 22 January 2025

22 January 2025

Data centre filled with rows of servers

Today, Cancer Research UK, the National Institute for Health and Care Research (NIHR) and the Engineering and Physical Sciences Research Council (EPSRC) are announcing £10 million to create the Cancer Data-Driven Detection programme, which aims to use data to identify individual cancer risk. Today, Cancer Research UK, the National Institute for Health and Care Research (NIHR) and the Engineering and Physical Sciences Research Council (EPSRC) are announcing £10 million to create the Cancer Data-Driven Detection programme, which aims to use data to identify individual cancer risk.

by Amy Warnock, Graeme Sneddon | News | 22 January 2025

22 January 2025

Patient seated at hospital, waiting for a doctor.

New analysis from our Cancer Intelligence team reveals that liver cancer death rates in the UK are almost twice as high as they were 20 years ago, making the disease the fastest rising cause of cancer death in the country. New analysis from our Cancer Intelligence team reveals that liver cancer death rates in the UK are almost twice as high as they were 20 years ago, making the disease the fastest rising cause of cancer death in the country.

by Sadaf Shafaghmotlagh | News | 15 January 2025

15 January 2025

A man in a bathroom opening a bowel cancer screening test kit (FIT kit) from NHS England.

NHS England's bowel cancer screening is expanding to 50 and 52-year-olds. Everyone 50 to 74 will now receive a FIT kit every two years. NHS England's bowel cancer screening is expanding to 50 and 52-year-olds. Everyone 50 to 74 will now receive a FIT kit every two years.

by Tim Gunn | News | 14 January 2025

14 January 2025